Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
52.3M
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
17.1M
-
Shares change
-
+3.88M
-
Total reported value, excl. options
-
$89.9M
-
Value change
-
+$21.2M
-
Put/Call ratio
-
0.72
-
Number of buys
-
59
-
Number of sells
-
-18
-
Price
-
$5.25
Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q2 2014
92 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q2 2014.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.1M shares
of 52.3M outstanding shares and own 32.78% of the company stock.
Largest 10 shareholders include DIMENSIONAL FUND ADVISORS LP (1.94M shares), BlackRock Institutional Trust Company, N.A. (1.41M shares), First Light Asset Management, LLC (1.11M shares), Clearbridge Investments, LLC (1.1M shares), VANGUARD GROUP INC (1.08M shares), MILLENNIUM MANAGEMENT LLC (1.03M shares), BlackRock Fund Advisors (856K shares), COLUMBIA PARTNERS L L C INVESTMENT MANAGEMENT (714K shares), EAM Investors, LLC (686K shares), and CORSAIR CAPITAL MANAGEMENT, L.P. (675K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.